Yongye Biotechnology's VP of Corporate Strategy Is Interviewed by The China Perspective

BEIJING, April 28 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading distributor of plant and animal nutrient products located in the People's Republic of China, today announced that Mr. Larry Gilmore, Yongye's VP of Corporate Finance, was interviewed by The China Perspective.

As a rapidly growing plant and animal nutrient products producer in China, Yongye welcomed the opportunity to be interviewed by The China Perspective (http://www.thechinaperspective.com/ ). The full interview is available at: http://tinyurl.com/dhh3oh .

In the interview, Mr. Gilmore spoke about how Yongye's products help Chinese farmers improve the quality and increase the quantity of their agricultural yields. He reviewed how Yongye recently expanded its production and sales capabilities to meet increasing demand for Yongye products from farmers. He expects Yongye's sales to increase throughout 2009 and explained why Yongye's products are attractive to farmers in China's currently difficult economic environment.

"The Chinese agricultural sector is dealing with difficult economic times. Yongye's products help farmers improve their production and grow their business," said Mr. Gilmore. "We are pleased by having an interview in The China Perspective which will let people know more about Yongye and how our products are being used to improve agriculture by China's farmers."

The China Perspective is a leading source of business news, research and analysis, which provides insight into the companies, industries and trends that are shaping the Chinese economy. For more information about The China Perspective, please visit http://www.thechinaperspective.com .

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the distribution and sales of fulvic acid based nutrients for plants and animals. The Company's patented and patent pending processes and proprietary formulas allow it to create products that improve crops and increase yields, and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia, People's Republic of China. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

The Company does not own any of its branded stores. Yongye works with distributors to target existing, independent agricultural stores which it believe meets its national branding criteria and then enters into agreements with storeowners through which the Company provides training about its products to storeowners and a computer to each store which contains educational and promotional information about the use of its products. Before becoming a Yongye branded store, stores are often physically cleaned and upgraded to meet the Company's national standards. Once a store becomes a Yongye branded store, Yongye's name is prominently displayed in front of the store, and its products are featured as headline products throughout the store through the use of various visual identity items. Storeowners receive direct marketing and product support from Yongye's service professionals and the opportunity to sell a high quality nationally marketed product.

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website ( http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Yongye Biotechnology International, Inc.
     Mr. Larry Gilmore, VP of Corporate Strategy
     and Principal Financial Officer
     Phone: +86-8232-8866 x8880
     Email: larry.gilmore@gmail.com

    CCG Investor Relations, Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com
     Web:   http://www.ccgirasia.com

SOURCE Yongye Biotechnology International, Inc.